VC firm investing in European growth stage digital health companies.
Led by the former Chief Strategy Officer of Sanofi & a digital health VC partner, KELES bridges the gap between start up innovation, international scaling and global impact.
We are uniquely positioned to access the best deals, enable scale up and maximize exit opportunities. We've sat at every seat around the table; from inception to exit to investor and acquirer, we know the economics and how-to of execution.
€250m Fund - Ticket Size €8m to €30m
KELES Investment Focus: Growth Stage - Demonstrated Profitability - Scaling Inflection Point
3 Core Digital Health Segments: New R&D Model (techbio/digitised trials) - Diagnostics (AI imaging/digital medtech) - Patient Care (acute/chronic)
The fund KELES S.C.Sp., SICAV - RAIF is established in Luxembourg, and we have bases in Paris, London and Brussels.
Company Details
- Employees
- 11
- Founded
- -
- Address
- Paris, London, Brussels, Luxembourg, Fr
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- https://keles.care
- Keywords
- Digital Health, Growth Stage, Europe.
- HQ
- Paris, London, Brussels, Luxembourg
Keles Questions
Keles's website is https://keles.care
Keles's LinkedIn profile is https://fr.linkedin.com/company/keles
Keles has
11 employees.
View email and phone details for 11
employees at Keles.
Keles's industry is
Venture Capital and Private Equity Principals
Keles's top competitors are
Neuro-Bio Ltd,
Fonds De Dotation Andurand,
Mica Biosystems,
Ballas Invest,
Investors In Healthcare,
Hitlab,
Creed Capital,
Ascension,
Buller Invest,
1004 Venture Partners.
Keles's categories are Venture Capital and Private Equity Principals
Keles's founding year is 2023
